MGC Diagnostics (MGCD) Q1 2017 Earnings Conference Call March 7, 2017 4:30 PM ET
Executives
Joe Dorame - Lytham Partners
Todd Austin - Chief Executive Officer
Wes Winnekins - Chief Financial and Risk Officer
Matt Margolies - President
Analysts
Mark Spiegel - Stanphyl Capital
Operator
Good afternoon, and welcome to the MGC Diagnostics First Quarter Fiscal Year 2017 Financial Results Conference Call. All participants will be in listen-only mode [Operator Instructions]. Please note, this event is being recorded.
I would now like to turn the conference over to Joe Dorame of Lytham Partners. Please go ahead sir.
Joe Dorame
Thank you, Amy. Good afternoon, everyone and thank you for participating in MGC Diagnostics' fiscal 2017 first quarter earnings conference call. My name again is Joe Dorame of Lytham Partners. We are the Investor Relations consulting firm for MGC Diagnostics Corporation.
Joining me today are Todd Austin, Chief Executive Officer; Wes Winnekins, Chief Financial Officer; and Mr. Matt Margolies, President. After our prepared remarks, we will open the call up to your questions.
Before we begin, let me remind you that some of the comments we will make during this conference call are forward-looking in nature and subject to certain risks and uncertainties. These factors are discussed in detail in our Form 10-K and our other filings with the Securities and Exchange Commission. We encourage you to review this material.
Also, this call is being recorded and will be available for replay starting today by dialing 877-344-7529 or 412-317-0088, the confirmation code is 10102288 and will be available through March 14, 2017. A webcast replay of the conference call will also be available on the company's website at www.mgcdiagnostics.com for a period of 90 days.
With that, I'd like to hand the call over to Todd. Todd?
Todd Austin
Thank you
- Read more current MGCD analysis and news
- View all earnings call transcripts